Earum Pharmaceuticals IPO vs Gensol Engineering IPO

Comparison between Earum Pharmaceuticals IPO and Gensol Engineering IPO.

IPO Details

Earum Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Gensol Engineering IPO is a SME Bookbuilding proposed to list at BSE SME.

Issue Size and Price

The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the Gensol Engineering IPO is up to ₹17.02 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of Gensol Engineering IPO is ₹83.00 per share.

 Earum Pharmaceuticals IPOGensol Engineering IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹81.00 per share
Issue Price (Upper)₹83.00 per share
Issue Price (Final)₹36.00 per share₹83.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size3000 shares1600 shares
Fresh Issue Size17,52,000 shares20,51,200 shares
Fresh Issue Size (Amount)up to ₹6.31 Crup to ₹17.02 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total17,52,000 shares20,51,200 shares
Issue Size Total (Amount)up to ₹6.31 Crup to ₹17.02 Cr

IPO Timetable

Earum Pharmaceuticals IPO opens on Jun 21, 2019, while Gensol Engineering IPO opens on Sep 30, 2019. The closing date of Earum Pharmaceuticals IPO and Gensol Engineering IPO is Jun 26, 2019, and Oct 04, 2019, respectively.

 Earum Pharmaceuticals IPOGensol Engineering IPO
Issue OpenJun 21, 2019Sep 30, 2019
Issue CloseJun 26, 2019Oct 04, 2019
Basis Of Allotment (Tentative)Jul 01, 2019Oct 10, 2019
Initiation of Refunds (Tentative)Jul 02, 2019Oct 11, 2019
Credit of Share (Tentative)Jul 03, 2019Oct 14, 2019
Listing date (Tentative)Jul 04, 2019Oct 15, 2019

Financials & KPIs

Earum Pharmaceuticals IPO P/E ratio is , as compared to Gensol Engineering IPO P/E ratio of .

 Earum Pharmaceuticals IPOGensol Engineering IPO
Financials

Company Financials (Restated)

Period Ended31 Dec 201831 Mar 201831 Mar 201731 Mar 2016
Assets27.4120.5311.088.79
Total Income34.5035.8523.6918.63
Profit After Tax0.870.860.160.10
EBITDA1.931.470.310.47
NET Worth5.084.211.531.37
Reserves and Surplus4.773.901.421.26
Total Borrowing7.897.232.081.90
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets42.8926.449.97
Total Income83.8569.6462.32
Profit After Tax6.495.341.19
EBITDA10.057.851.82
NET Worth13.046.551.21
Reserves and Surplus7.006.531.20
Total Borrowing8.611.240.39
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%96%
Promoter Shareholding (Post-Issue)70.04%70.72%
Market Cap₹22.20 Cr.₹68.08 Cr.

Shares Offered

In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in Gensol Engineering IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in Gensol Engineering IPO.

 Earum Pharmaceuticals IPOGensol Engineering IPO
Market Maker Reservation96,000 shares1,08,800 shares
NII8,76,000 shares10,25,600 shares
RII8,76,000 shares10,25,600 shares
Total17,52,000 shares20,51,200 shares

Bids Received (Subscription)

Earum Pharmaceuticals IPO subscribed 1.60x in total, whereas Gensol Engineering IPO subscribed 1.32x.

Compare with others

Compare:

Earum Pharmaceuticals IPO Vs Gensol Engineering IPO